We’ve known for a while that Facebook is struggling with the strain of the strain known as Weber Syndrome, which has infected millions of users with the chronic health problems of a brain infection.
Now it turns out the company’s CEO is in the same boat.
Mark Zuckerberg was hospitalized in December with an infection that left him in a coma for several days.
That’s not a good sign for a company that already has its sights set on the Olympics, which are just weeks away.
In addition to the viral pandemic, Zuckerberg’s wife, Priscilla Chan, also is battling brain cancer.
And he recently had surgery to remove an ulcer from his left kidney, which doctors hope will ease his pain.
As the head of Facebook, Zuckerberg has spent much of the last several weeks in intensive care.
The company released a statement Tuesday saying he’s in “stable but stable condition.”
Zuckerberg, 52, has been battling Weber for a few months now.
Weber is a serious condition that affects about 1 in 100 people, according to a 2014 study.
Symptoms include confusion, loss of coordination and hallucinations.
The condition affects roughly 2 percent of people, or less than half of people who have it.
It can cause mental retardation, seizures and even death.
It’s hard to predict when the condition will strike again, but we don’t expect it to be as bad as it was before the pandemic.
As Zuckerberg has been suffering from Weber, his colleagues have also been suffering.
Facebook’s CEO has had some tough times.
He’s been the subject of a series of internal investigations into his handling of a scandal involving Russian election meddling and his hiring of an ex-girlfriend to work on his social network.
Zuckerberg’s troubles haven’t gone unnoticed by some in the company.
The social network has said it’s committed to keeping people in a safe environment.
Facebook, which is valued at $68 billion, has spent the past several months trying to shore up its stock price, with executives saying the stock price is at an all-time high and that the company will not have to go through another stock market correction.